Medilink Award for Innovation
DYSIS Medical Ltd
(DYSIS or the Company)
DYSIS Medical receives National Innovation Award
Company named as winner at the NHS Innovation Expo
Edinburgh – 13March 2013 – DYSIS Medical Ltd, the medical devices company in female health, was revealed today as the winner of the Innovation Award for 2013 at the annual awards ceremony.
DYSIS colposcopy uses spectral imaging to help clinicians highlight any areas of concern by mapping out the condition of a woman’s cervix. In clinical trials, it has been shown to significantly boost sensitivity in detecting cervical cancer in its earliest stages. Armed with this additional information, clinicians are able to take immediate steps to treat patients and prevent disease progression.
The presentation was made at the NHS Healthcare Innovation Expo at the ExCel Centre in London, which is an annual event that celebrates cutting edge technologies, outstanding business achievements and international success across the UK’s Life Science sector. DYSIS Medical was short-listed for this Award having won the Scottish Life Sciences award two weeks earlier.
DYSIS Medical CEO, Alastair Atkinson said “Winning this national award on top of the Scottish Life Science Award for Innovation is another great testament of our product’s ability to make a difference to patient outcomes at a lower cost”.
Tony Davis, Medilink UK’s Chairman, said: “Set against the backdrop of innovation and wealth creation, driven by the Department of Health’s (DH) Innovation, Health and Wealth strategy, NHS Expo was a great opportunity to celebrate the excellence of the UK’s Life Sciences sector through the Medilink UK Awards. I would like to extend massive congratulations to all of our winners. Their success is further proof that our sector is in excellent health and gives us great encouragement for the years ahead.”
For more information, please contact:
DYSIS Medical Ltd Tel: +44 (0)1506 592159
Alastair Atkinson, CEO
College Hill (PR for DYSIS Medical) Tel: +44 (0)20 7457 2020
Melanie Toyne Sewell / Gemma Howe
Notes to Editors
DYSIS Medical Ltd
DYSIS Medical Ltd has its global headquarters in Edinburgh. The company is committed to saving lives through the early detection and diagnosis of disease using biophotonic innovations. It aims to be the global leader in automated optical molecular imaging technologies for medical diagnostic and screening applications. For more information, please visit: www.dysismedical.com
The DYSIS cervical cancer screening product employs advanced photonics and computer assistance to quantify and map the aceto-whitening process – providing clinicians with reliable information to assist in the identification of pre-cancerous lesions. The product is sold in Europe and the US.